Amendment to PAR-06-293, Quick-Trials for Imaging and Image-Guided Interventions: Exploratory Grants (R21)

Notice Number: NOT-CA-06-027

Key Dates
Release Date: May 19, 2006

Issued by
National Cancer Institute (NCI) (http://www.nci.nih.gov)

Amendment
This Notice is to inform the scientific community that the NCI is amending Program Announcement PAR-06-293, Quick-Trials for Imaging and Image-Guided Interventions: Exploratory Grants (R21), in order to correct an inadvertent error regarding the allowable total direct cost budget request for the entire requested funding period of 2 years maximum. Per this Notice, the total direct cost budget request in any application submitted in response to PAR-06-293 can be no more than $500,000 over the entire maximum requested funding period of 2 years; this limit continues the policy set for the prior related program announcement, PAR-05-114, for which PAR-06-293 is the reissued funding opportunity announcement.

Therefore, the statement “Direct costs are limited to $275,000 over an R21 2-year period, with no more than $200,000 in direct costs allowed in any single year” that appears in the Executive Summary of PAR-06-293 is hereby replaced by “Direct costs are limited to $500,000 over an R21 2-year period, with no more than $250,000 in direct costs allowed in any single year,” and the statements “R21 applications will use the modular budget format and "Just-in-Time" concepts, with direct costs requested in $25,000 modules, up to the total direct costs limitation of $275,000 over an R21 2-year period. No more than $200,000 in direct costs will be allowed in any single year.” that appears in Section IV.6. of PAR-06-293 is hereby replaced by “R21 applications will use the modular budget format and "Just-in-Time" concepts, with direct costs requested in $25,000 modules, up to the total direct costs limitation of $500,000 over an R21 2-year period. No more than $250,000 in direct costs will be allowed in any single year.”

Inquiries
Direct questions about this change to:

Lalitha K. Shankar, M.D., Ph.D. or Keyvan Farahani, Ph.D.
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
6130 Executive Boulevard, EPN Room 6048, MSC 7412
Bethesda, MD 20892-7412 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for express/courier delivery)
Phone: 301-496-9531
Fax : 301-480-3507
E-mail: shankarl@mail.nih.gov or farahank@mail.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.